The Fact Sheet provides information on the aim and objective of providing the one-off A$10 million grant to support the establishment of a small-scale mammalian cell production facility in Australia.
It also provides some key findings from the independent Business Case study, which are:
- there is a niche market opportunity for Australia;
- $35 million of mammalian cell based clinical development work is sent to offshore Contract Manufacturing Organisations each year;
- an Australian facility could earn between $32 and $62 million per annum; and
- a facility would have positive net present values and reasonable internal rates of return of up to 34 per cent.
Please note: Applicants were advised to undertake their own analysis and not rely on indicative information provided by the Business Case study.
Please note: Applications closed 17 August 2007.
Return to Mammalian cell production facility main page.
Who to contact?
For further information about the Australian Government grant please contact:
|
Peter Chesworth
Tel: +61 2 6213 6058 |
|
|
Email |
|
Pharmaceuticals and Medical Technology Section
Department of Innovation, Industry, Science and Resources
GPO Box 9839
CANBERRA ACT 2601
Tel: +61 2 6213 6597
Email